United States · Biotechnology startup

Jnana Therapeutics

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Funding reportedLast round: Series C

BiotechnologyBoston, United States

What company datasets say Jnana Therapeutics raised

Funding, as reported

Reported in all$207Min dollars
Rounds3
Last roundSeries C
Last round dateNov 2022
Investors listed8
SEC Form D$217M sold, 3 filings, last Jan 2024

Founders and team

From Jnana Therapeutics's own website and the SEC filings it signed: 1 founder, 5 on the team.

Scientific CofoundersCofounder and Founding CEO
  • Joanne D. KotzChief Executive Officer, Treasurer, Secretary and Directori
  • George W. VratsanosChief Medical Officer and Head of R&Di
  • James SauerChief Financial Officer
  • Caroline Stark BeerChief Business Officeri
  • Douglas W. PaganChief Financial Officer and Chief Operating Officeri

On the board, as filediAnnie C. ChenBrian M. CaliCarlo W. RizzutoDonald W. NicholsonMatthew W. HammondRonald C. RenaudTerrance G. McGuire

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Jnana Therapeutics in front of investors. Or tell us what we have wrong.

List your startupSend a correction